ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) announced that it has completed the sale of its European operations to Incyte Corporation and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE